Hill August 29, 2023
Alex Gangitano

President Biden on Tuesday vowed to not back down from pharmaceutical companies in touting the first 10 drugs chosen for Medicare price negotiation under the Inflation Reduction Act (IRA).

“Big Pharma charging Americans more than three times what they charge other countries simply because they could and I think it’s outrageous. That’s why these negotiations matter,” Biden said at an event at the White House.

“We’re going to keep standing up to Big Pharma, and we’re not gonna back down.”

The drugs, announced Tuesday by the White House, were chosen based on their eligibility under the Inflation Reduction Act, and they account for an estimated $50.5 billion in total gross Medicare Part D costs.

“Finally, finally, finally we had enough...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
109 hospitals receiving new Medicare-backed residency slots
Senators urge Congress to avert Medicare physician pay cut
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes

Share This Article